Skip to main content
Livermore
Livermore
ZHEN

First Light Asset Management, LLC

SEC CIK
0001600004
Latest filing
Aug 14, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by First Light Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of RARE by First Light Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−285,699−100.0%Sold outHolders
Q3 2025285,699$8.59M0.8%−262,206−47.9%ReducedHolders
Q2 2025547,905$19.9M2.6%−84,128−13.3%ReducedHolders
Q1 2025632,033$22.9M2.6%−131,574−17.2%ReducedHolders
Q4 2024763,607$32.1M3.1%+8,505+1.1%AddedHolders
Q3 2024755,102$41.9M3.5%−208,044−21.6%ReducedHolders
Q2 2024963,146$39.6M3.5%+172,700+21.8%AddedHolders
Q1 2024790,446$36.9M2.8%+45,781+6.1%AddedHolders
Q4 2023744,665$35.6M2.9%−380,367−33.8%ReducedHolders
Q3 20231,125,032$40.1M3.8%+535,069+90.7%AddedHolders
Q2 2023589,963$27.2M2.1%+354,186+150.2%AddedHolders
Q1 2023235,777$9.45M0.9%+1,478+0.6%AddedHolders
Q4 2022234,299$10.9M1.0%−219,495−48.4%ReducedHolders
Q3 2022453,794$18.8M1.9%+1,324+0.3%AddedHolders
Q2 2022452,470$27.0M3.1%+14,958+3.4%AddedHolders
Q1 2022437,512$31.8M2.8%+26,199+6.4%AddedHolders
Q4 2021411,313$34.6M2.5%−29,846−6.8%ReducedHolders
Q3 2021441,159$39.8M2.6%+211,913+92.4%AddedHolders
Q2 2021229,246$21.9M1.3%+11,787+5.4%AddedHolders
Q1 2021217,459$24.8M1.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.